InnoCan Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	30	30	60	83	54	199
Market Cap Growth	-36.23%	-49.98%	-27.47%	54.74%	-72.99%	218.14%
Enterprise Value	25	26	56	78	45	191
Last Close Price	6.58	6.70	13.65	20.15	13.97	52.00
PS Ratio	0.81	0.83	1.42	4.61	15.50	801.47
PB Ratio	2.62	2.67	5.96	14.34	6.37	17.43
P/TBV Ratio	3.86	3.93	8.11	15.33	6.20	17.35
P/FCF Ratio	45.07	45.89	-	-	-	-
P/OCF Ratio	43.62	44.41	-	-	-	-
EV/Sales Ratio	0.69	0.71	1.32	4.32	12.89	771.51
EV/FCF Ratio	38.56	39.60	-	-	-	-
Debt / Equity Ratio	0.11	0.11	0.00	0.01	0.01	0
Debt / FCF Ratio	1.94	1.94	-	-	-	-
Net Debt / Equity Ratio	-0.70	-0.70	-0.71	-0.88	-0.79	-1.23
Net Debt / EBITDA Ratio	4.75	4.75	4.12	1.02	0.79	1.49
Net Debt / FCF Ratio	-12.02	-12.02	3.14	0.98	0.81	1.66
Asset Turnover	2.69	2.69	3.63	1.96	0.26	0.02
Inventory Turnover	0.98	0.98	1.28	1.17	0.55	0.16
Quick Ratio	5.63	5.63	2.48	1.79	7.10	3.15
Current Ratio	7.70	7.70	4.09	2.68	9.41	3.51
Return on Equity (ROE)	-4.47%	-4.47%	-4.59%	-80.07%	-51.05%	-373.46%
Return on Assets (ROA)	-7.93%	-7.93%	-9.62%	-34.16%	-40.06%	-55.30%
Return on Invested Capital (ROIC)	299.24%	223.57%	27.80%	-412.03%	-	-
Return on Capital Employed (ROCE)	-13.70%	-13.70%	-17.80%	-86.50%	-100.30%	-83.00%
Earnings Yield	-5.21%	-5.11%	-4.38%	-7.47%	-9.49%	-6.40%
FCF Yield	2.22%	2.18%	-3.81%	-6.28%	-15.36%	-4.25%
Buyback Yield / Dilution	-3.92%	-3.92%	-8.96%	-3.23%	-10.87%	-38.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.